本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Surface Oncology

1.07
0.0000
成交量:- -
成交額:158.71萬
市值:6,508.22萬
市盈率:-0.70
高:1.07
開:1.07
低:1.07
收:1.07
52周最高:1.43
52周最低:0.5550
股本:6,082.45萬
流通股本:4,827.47萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.5347
每股收益(LYR):-1.1403
淨資產收益率:-105.78%
總資產收益率:-41.42%
市淨率:1.32
市盈率(LYR):-0.94

資料載入中...

2023/06/17

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/17

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/17

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/17

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

重要事件披露

Form 8-K - Current report
2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/05/04

重要事件披露

8-K - Current report
2023/05/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/01

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/09

重要事件披露

8-K - Current report
2023/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans